发明名称 Chromic picolinate treatment
摘要 The administration of chromic picolinate, preferably in the form of chromic tripicolinate, as a prophylactic or therapeutic agent for controlling various blood serum parameters. In particular, the administration is for controlling blood serum lipid levels, including the lowering of undesirably high blood serum LDL-cholesterol levels and the raising of blood serum HDL-cholesterol levels. Additionally, the adminstration is for controlling desirable high blood serum glucose levels, this being particularly applicable for the treatment of maturity-onset diabetes. Additionally, chromic picolinate, preferably in the form of chromic tripicolinate, is admistered to facilitate uptake of amino acids by skeletal muscle. Thus chromic picolinate can act as an effective anabolic agent.
申请公布号 US5087623(A) 申请公布日期 1992.02.11
申请号 US19890326590 申请日期 1989.03.21
申请人 NITRITION 21 发明人 BOYNTON, HERB;EVANS, GARY W.
分类号 A61K31/555 主分类号 A61K31/555
代理机构 代理人
主权项
地址